Maintaining Muscle Mitochondria via Transsynaptic Signaling  by Long, Jennifer B. & Van Vactor, David
Developmental Cell
Previewstension. Furthermore, although cell
tension-mediated inhibition appears to
be critical in maintaining neutrophil
polarization, it is unlikely to be the only
inhibitory signal. In fact, the most recent
model for cell migration proposes that
two parallel activator and inhibitor
branches are required (Iglesias and
Devreotes, 2011). In this context, the
identification of the molecular compo-
nents involved in transducing membrane
tension signals will provide important
insight into our understanding of how cells
establish polarity.238 Developmental Cell 22, February 14, 201REFERENCES
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Dominant VAPB mutations are implicated in neurodegenerative disease, including amyotrophic lateral
sclerosis and spinal muscular atrophy. In the current issue, Han et al. (2012) uncover a mechanism through
which the secreted VAPB MSP domain regulates actin organization and mitochondrial function in muscle
cells through LAR and Robo receptor activation.Motor neuron diseases such as amyotro-
phic lateral sclerosis (ALS) and spinal
muscular atrophy (SMA) are character-
ized by progressive motor neuron loss
and subsequent muscle atrophy, leading
to paralysis and ultimately death via
respiratory failure (Van Den Bosch and
Timmerman, 2006). Both environmental
and genetic factors have been attributed
to the pathology of ALS; familial cases
account for approximately 10% of all
cases. Despite the limited genetic sus-
ceptibility of ALS, it is now known that
a variety of mutations identified in familial
ALS may also contribute to many
sporadic cases (Pasinelli and Brown,
2006). Thus, understanding the mecha-
nisms by which these mutations cause
motor neuron death may lead to novel
therapeutic strategies.
New work by Han et al. (2012) investi-
gates the role of synaptobrevin/VAMP
(vesicle-associated membrane protein)-associated protein B (VAPB) in muscle
mitochondrial regulation. VAPB has
been implicated in motor neuron survival
and mutations in VAPB have been
identified both in ALS and SMA patients
(Van Den Bosch and Timmerman,
2006). Moreover, functional and morpho-
logical defects in skeletal muscle mito-
chondria have been linked to both
familial and sporadic ALS (Duffy et al.,
2011; Pasinelli and Brown, 2006). Here,
the authors demonstrate that VAPB has
a cleaved and secreted major sperm
protein (MSP) domain that signals
through leukocyte-antigen related (LAR)
and Roundabout (Robo) family receptors
on the muscle cell surface and that
ultimately leads to alterations in actin
organization and changes mitochondrial
morphology and function.
VAPB is amember of a highly conserved
protein family that localizes to the endo-
plasmic reticulum (ER) and is involved ina variety of functions, including mainte-
nance of ER morphology, vesicular traf-
ficking, and intracellular lipid transport
regulation (Tsuda et al., 2008). The
N-terminal MSP domain of VAPB is
cleaved and secreted, serving as an extra-
cellular ligand. MSP was originally identi-
fied as a sperm-derived secreted protein
that is required for oocyte maturation in
nematodes. Previous work by this group
identified a role for secreted MSPs in
motor neuron degeneration via the con-
served axon guidance receptor Eph
(Tsuda et al., 2008). A dominantly
inherited proline 56 to serine (P56S) muta-
tion within the secreted MSP domain is
associated with both ALS and SMA
(Tsuda et al., 2008; Van Den Bosch and
Timmerman, 2006). The P56S mutation
serves as a dominant-negative and antag-
onizes the endogenous wild-type func-
tion of VAPB by promoting VAPB ubiq-
uitination, recruitment into cytoplasmic
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Previewsinclusions, and abnormal MSP process-
ing, ultimately leading to motor neuron
degeneration and death (Tsuda et al.,
2008). Now Han et al. (2012) highlight an
important role for the MSP domain of
VAPB in the pathophysiology of motor
neuron disease through its influence on
postsynaptic partners, contributing to
muscle atrophy and cell death.
In this exciting new study, Han et al.
(2012) use both Drosophila melanogaster
and Caenorhabditis elegans to demon-
strate that VAPB mutants have abnormal
mitochondrial morphology and aberrant
interconnected mitochondrial tubules.
Mitochondria are highly dynamic struc-
tures. Mitochondrial number and the
morphology of the mitochondrial network
rely on cycles of fission and fusion events.
For example, as mitochondria cannot
replicate de novo, fission may occur to
ensure enough mitochondria are present
to meet energy demands (Knott and
Bossy-Wetzel, 2008). In contrast, mito-
chondrial fusion often serves to repair or
restore damaged segments of mitochon-
dria, as metabolites, proteins, and mito-
chondrial DNA can move between fused
segments. The phenotype Han et al.
(2012) observe in VAPBmutants suggests
an imbalance of mitochondrial fission
and fusion in muscle, which has been
implicated in neurodegeneration (Knott
and Bossy-Wetzel, 2008). In addition to
morphology defects, VAPB mutants
display mislocalized mitochondria, which
suggests defects in mitochondrial
motility. Finally, both worm and fly VAPB
mutants display impaired mitochondrial
function, decreased electron transport
chain activity, and reactive oxygen
species (ROS). These data reinforce
previous work implicating muscle mito-
chondrial function in the pathogenesis
of ALS (Pasinelli and Brown, 2006). Inter-
estingly, this novel activity of VAPB is
strictly dependent on the cleavage
and secretion of the MSP domain in
neurons. The VAPBP56S mutant protein
is retained within the ER in neurons
and therefore neither cleaved nor se-
creted. When Han et al. (2012) express
VAPBP56S in muscle, they find no
phenotype, but neuronal expression
induces mitochondrial defects in muscle,
revealing a nonautonomous mechanism.
In motor neurons, secreted MSPs signal
through EphR (Tsuda et al., 2008), butin muscle, loss of EphR does not alter
mitochondrial phenotypes. Thus, Han
et al. (2012) search for an alternate
receptor to account for MSP transsynap-
tic signaling to muscle cells.
Using genome-wide microarrays and
subsequent functional analysis, Han
et al. (2012) identify two additional MSP
receptors. Like Eph receptors, LAR and
Robo family receptors are highly con-
served and mediate multiple axon guid-
ance decisions during nervous system
development (Lowery and Van Vactor,
2009). The authors demonstrate that
both LAR and Robomutants have altered
muscle mitochondrial morphology and
function in C. elegans. Interestingly, both
VAPB andRobo antagonize LAR signaling
in muscle. Other groups have demon-
strated evidence of genetic interactions,
shared signaling pathways, and down-
stream effectors between LAR and Robo
in neurons. For example, Robo and LAR
have opposing functions during midline
axon guidance in Drosophila, indicating
some type of inhibitory crosstalk between
these two receptors (e.g., Sun et al.,
2000). The data presented by Han et al.
in muscle provides additional evidence
of crosstalk between LAR and Robo.
Han et al. propose the intriguing hypoth-
esis that Robo and LAR act as co-recep-
tors, with Robo promoting LAR-MSP
binding to inhibit LAR activity. This model
shares features with another signaling
role for Robo, which underlies a switch
in responsiveness of commissural axons
to Netrin following midline crossing by
binding to and silencing the receptor
DCC (Stein et al., 2001).
Robo and LAR regulate downstream
signaling molecules that control cytoskel-
etal dynamics and network organization.
In the current study, the authors show
that the MSP-dependent activation of
Robo and subsequent downregulation of
LAR signaling alters the activity of the
actin-related protein (Arp2/3) complex, an
actin nucleator and branching factor that
hasbeen implicated in cellmorphogenesis
and motility in many contexts (Boldogh
et al., 2001). However, in neurons, LAR
and Robo engagemultiple signalingmole-
cules and cytoskeletal effectors, including
Rho-family GTPase regulators and the
Abelson kinase, the actin assembly
factor Enabled (Ena), the actin nucleator
Diaphenous (Dia), the actin-microtubuleDevelopmental Cell 22,crosslinker Short Stop (Shot), and the
microtubule plus-end tracking factor
CLASP (Lowery and Van Vactor, 2009).
Interestingly, mitochondrial transport and
localization in axons is primarily microtu-
bule-dependent (Duffy et al., 2011).
The arsenal of actin and microtubule
effectors downstream of LAR and Robo
raises intriguing questions regarding
the complexity and specificity of the
regulatory process that supports normal
mitochondrial structure and function in
muscle cells downstream of VAPB. Is
the integration between Robo and LAR
at the cell surface where the VAPB MSP
binds or somewhere downstream inside
of the responding cell? Is it possible that
specialized mitochondrial properties are
required at synaptic sites for normal
physiology, thus explaining both the role
of motor neurons in defining a specific
spatial domain for mitochondria in muscle
via VAPB-Robo/LAR signaling and the
importance of this pathway in protecting
neuromuscular circuits from neurodegen-
erative losses? Han et al. (2012) have
opened an exciting doorway to the cell
biology of mitochondria through which
many new answers will undoubtedly
arrive.
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